Breast cancer breakthrough: testing if patients can stop treatment safely
NCT ID NCT05721248
Summary
This study is testing whether patients with advanced HER2-positive breast cancer can safely stop their targeted treatment after having their cancer under control for at least three years. The trial involves 82 participants who will either continue treatment or stop it, with researchers monitoring their cancer through blood tests and scans. The goal is to understand if certain patients can maintain their health without ongoing treatment and identify markers that predict who can stop safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
DFCI @ Foxborough
Foxborough, Massachusetts, 02035, United States
-
DFCI @ Merrimack Valley
Methuen, Massachusetts, 01844, United States
-
DFCI @ Milford Regional Hospital
Milford, Massachusetts, 01757, United States
-
DFCI @ South Shore Hospital
South Weymouth, Massachusetts, 02190, United States
-
Dana-Farber Cancer Insitute
Boston, Massachusetts, 02215, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 02809, United States
-
Mayo Clinic Hospital Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Mayo Clinical Hospital Florida
Jacksonville, Florida, 32224, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.